Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.58 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 2/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 8/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.53 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.52 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6792538 | 1.00 | TRPA1 (0.58) | TRPA1TRPM8MAOBPTGS1HDAC1 | |
| SCHEMBL6788179 | 0.84 | MEN1 (0.54) | TRPA1TRPM8MAOBPTGS1 | |
| SCHEMBL6788183 | 0.84 | MEN1 (0.54) | TRPA1TRPM8MAOBPTGS1 | |
| SCHEMBL6789824 | 0.82 | DHODH (0.54) | TRPA1TRPM8MAOBPTGS1MCHR1 | |
| SCHEMBL6789833 | 0.82 | DHODH (0.54) | TRPA1TRPM8MAOBPTGS1MCHR1 | |
| SCHEMBL6791069 | 0.80 | PTGS1 (0.58) | PTGS1HDAC1HDAC2HDAC3 | |
| SCHEMBL3886435 | 0.80 | PTGS1 (0.53) | PTGS1 | |
| SCHEMBL3886439 | 0.80 | PTGS1 (0.53) | PTGS1 | |
| SCHEMBL6787881 | 0.79 | PTGS1 (0.56) | PTGS1HDAC1HDAC3 | |
| SCHEMBL6791178 | 0.79 | PTGS1 (0.67) | PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058903-A1 | Benzamide compounds as apo b secretion inhibitors | APOB, APOL1, SCARB1 | TRPA1 2951/4885TRPM8 2469/4885MAOB 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.